Crism Therapeutics Corporation Ord Npv (CRTX)

Sector:

Investment Firms

Index:

FTSE AIM All-Share

 9.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 18.00p
  • 52 Week Low: 8.00p
  • Currency: UK Pounds
  • Shares Issued: 32.68m
  • Volume: 52,308
  • Market Cap: £3.10m

CRTX Overview

Founded in March 2016, CRISM Therapeutics employs an interdisciplinary team of pharmaceutical specialists based in Birmingham. We serve a wide range of international clients, aiming to improve the clinical performance of active pharmaceutical ingredients (APIs) via local drug delivery and personalised medicines.

Key Personnel

CEO: Andrew James Webb
Chief Scientific Officer: Christopher McConville
Independent Non-Executive Director: Gerald Beaney
Non-Executive Chairman: Nermeen Yunus Varawalla
Non-Executive Dir:

Contact Details

Address: Kingston Chambers, PO Box 173, Road Town, Tortola, British Virgin Islands, USA,
Phone: +1 (925) 408 4621
Website: http://www.crismtherapeutics.com/

Listings

Sector: Investment Firms(LSE)
Index: FTSE AIM All-Share
ISIN: VGG042401262

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CRTX Market Data

Currency UK Pounds
Share Price 9.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 18.00p
52 Week Low 8.00p
Volume 52,308
Shares Issued 32.68m
Market Cap £3.10m

CRTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Value Not Available
Income Not Available
Growth Not Available

CRTX Dividends

  Latest Previous
  Special Interim
Ex-Div 01-Jun-23 n/a
Paid 14-Jun-23 n/a
Amount 1.80p 0.000¢

Trades for 01-Apr-2025

Time Volume / Share Price
14:31 32 @ 8.60p
09:41 1,386 @ 8.60p
08:55 3,125 @ 8.60p
08:37 631 @ 8.00p
08:29 16,609 @ 8.60p

CRTX Key Personnel

CEO Andrew James Webb

Top of Page